We have located links that may give you full text access.
Clinical Trial
Journal Article
Randomized Controlled Trial
Oral creatine supplementation improves multiple sprint performance in elite ice-hockey players.
Journal of Sports Medicine and Physical Fitness 1999 September
BACKGROUND: The purpose of this study was to assess the effect of oral creatine monohydrate supplementation on multiple sprint cycle and skating performance in ice-hockey players.
PARTICIPANTS: sixteen elite ice-hockey players were selected as subjects.
EXPERIMENTAL DESIGN: subjects were randomly assigned to either a creatine (Cr) (n = 8) or a placebo (P) group (n = 8) in a double blind design. After familiarization and baseline tests, subjects loaded with 5 g of creatine monohydrate or placebo (glucose) four times per day for 5 days, after which a maintenance dose of 5 g per day for 10 weeks was administered. At baseline, and after 10 days and 10 weeks of supplementation, subjects performed i) a cycle test involving 5 all-out sprints of 15 sec duration separated by 15 sec recovery with the resistance set at 0.075 body mass (kg), and ii) 6 timed 80-m skating sprints with the sprints initiated every 30 sec and a split time taken at 47 m.
RESULTS: A two-way ANOVA demonstrated no significant change in any of the variables in the P group over the period of study. However, in the Cr group, average mean power output over the 5 sprints was significantly higher at 10 days (1074 +/- 241 W) and 10 weeks (1025 +/- 216 W) than at baseline (890 +/- 172 W), (p < 0.01). Average peak power output over the 5 sprints improved significantly from baseline (1294 +/- 311 W) to 10 days (1572 +/- 463 W), (p < 0.01). Average on-ice sprint performance to 47 m was significantly faster at 10 days (6.88 +/- 0.21 sec) and 10 weeks (6.96 +/- 0.19 sec) than at baseline (7.17 +/- 0.27 sec), (p < 0.005).
CONCLUSIONS: This study demonstrates that creatine supplementation has an ergogenic effect in elite ice-hockey players.
PARTICIPANTS: sixteen elite ice-hockey players were selected as subjects.
EXPERIMENTAL DESIGN: subjects were randomly assigned to either a creatine (Cr) (n = 8) or a placebo (P) group (n = 8) in a double blind design. After familiarization and baseline tests, subjects loaded with 5 g of creatine monohydrate or placebo (glucose) four times per day for 5 days, after which a maintenance dose of 5 g per day for 10 weeks was administered. At baseline, and after 10 days and 10 weeks of supplementation, subjects performed i) a cycle test involving 5 all-out sprints of 15 sec duration separated by 15 sec recovery with the resistance set at 0.075 body mass (kg), and ii) 6 timed 80-m skating sprints with the sprints initiated every 30 sec and a split time taken at 47 m.
RESULTS: A two-way ANOVA demonstrated no significant change in any of the variables in the P group over the period of study. However, in the Cr group, average mean power output over the 5 sprints was significantly higher at 10 days (1074 +/- 241 W) and 10 weeks (1025 +/- 216 W) than at baseline (890 +/- 172 W), (p < 0.01). Average peak power output over the 5 sprints improved significantly from baseline (1294 +/- 311 W) to 10 days (1572 +/- 463 W), (p < 0.01). Average on-ice sprint performance to 47 m was significantly faster at 10 days (6.88 +/- 0.21 sec) and 10 weeks (6.96 +/- 0.19 sec) than at baseline (7.17 +/- 0.27 sec), (p < 0.005).
CONCLUSIONS: This study demonstrates that creatine supplementation has an ergogenic effect in elite ice-hockey players.
Full text links
Related Resources
Trending Papers
Challenges in Septic Shock: From New Hemodynamics to Blood Purification Therapies.Journal of Personalized Medicine 2024 Februrary 4
Molecular Targets of Novel Therapeutics for Diabetic Kidney Disease: A New Era of Nephroprotection.International Journal of Molecular Sciences 2024 April 4
The 'Ten Commandments' for the 2023 European Society of Cardiology guidelines for the management of endocarditis.European Heart Journal 2024 April 18
A Guide to the Use of Vasopressors and Inotropes for Patients in Shock.Journal of Intensive Care Medicine 2024 April 14
Diagnosis and Management of Cardiac Sarcoidosis: A Scientific Statement From the American Heart Association.Circulation 2024 April 19
Essential thrombocythaemia: A contemporary approach with new drugs on the horizon.British Journal of Haematology 2024 April 9
Get seemless 1-tap access through your institution/university
For the best experience, use the Read mobile app
All material on this website is protected by copyright, Copyright © 1994-2024 by WebMD LLC.
This website also contains material copyrighted by 3rd parties.
By using this service, you agree to our terms of use and privacy policy.
Your Privacy Choices
You can now claim free CME credits for this literature searchClaim now
Get seemless 1-tap access through your institution/university
For the best experience, use the Read mobile app